Diabetes Technology Meeting

Virtual Poster Session: November 11, 2021, 8:30 - 13:00 Free Registration

Please join us for the oral presentation and moderated discussion of the top 36 abstracts submitted to the 2021 Virtual Diabetes Technology Meeting. This session is free for all to attend. 

Thursday, November 11, 2021

Virtual Poster Session (All Times Pacific)

Session A

Moderators

Nestoras Mathioudakis, MD

Johns Hopkins University, Baltimore, Maryland, USA

 

Jessica Castle, MD

Oregon Health & Science University, Portland, Oregon, USA

 

8:30    Outpatient Full Closed-Loop Trial Using An Open-Source Remote Monitoring and Artificial Pancreas Platform

Fabricio Garelli, PhD et al.

Presented by Emilia Fushimi, Eng.

 

8:34    Significant Reductions in Adverse Events and Hospitalizations with Control-IQ Technology in Adults with Type 1 Diabetes: Data from the CLIO Study

Jordan E. Pinsker, MD et al.

 

8:38    Impact of Real-World MiniMed™ 670G System Use on Glycemic Outcomes in the United States

Siddharth Arunachalam, MSc et al.

 

8:42    Real-World Outcomes of the MiniMedTM 780G System when Used with Optimal Settings

Arcelia Arrieta, MS et al.

Presented by Ohad Cohen, MD

 

8:46    Current Technology Use in Pediatric Patients with Type 1 Diabetes: An Equity-Focused Analysis

Katie Fogle, BS

 

8:50    Higher Dose of Inhaled Technosphere Insulin Provides Significant Reduction in Post Prandial Glucose Excursions, Without Hypoglycemia

Kevin Kaiserman, MD et al.

 

8:54    Q&A / Panel Discussion

 

 

Session B

Moderators

Julia Mader, MD, PhD

Medical University of Graz, Graz, Austria

 

Boris Kovatchev, PhD

University of Virginia, Charlottesville, Virginia, USA

 

9:15    Hyperoptimized DeepLearning Model For Glucose Prediction On DBLG1

Hector Romero-Ugalde, PhD et al.

 

9:19    Predicting Postprandial Glucose Excursions with Macronutrient Content using an Interpretable Random Forest Augmented by a Digital Twin ODE Model

Rahul Narayan, MS et al.

 

9:23    In Silico Trial to Quantitatively Measure How Much Different Behavioural Factors Influence Time in Hypoglycemia in Type 1 Diabetes Management

Chiara Roversi, MS et al.

 

9:27    Importance of Accounting for Correlation Among Noise Samples when Filtering CGM Data: A Simulation Study

Ilaria Siviero, MS et al.

Presented by Nunzio Camerlingo, MSc

 

9:31    Evaluation of the Safety and Efficacy of the Lalani Insulin Infusion Protocol

Benjamin Lalani et al.

 

9:35    Generation of Realistic Virtual Diabetes Patients Using a Pix2Pix GAN: In Pursuit of AI-based Diabetes Simulator

Omer Mujahid, MSc et al.

 

9:39    Q&A / Panel Discussion

 

Session C

Moderators

Boris Mankovksy, MD, PhD

Institute of Endocrinology, Kiev, Ukraine

 

Mike McShane, PhD

Texas A&M University, College Station, Texas, USA

 

10:00  Post-Market Clinical Surveillance of OneTouch Ultra® Plus Blood Glucose Test Strips

Steven Setford, PhD et al.

 

10:04  Clinical Evaluation of the Lumee™ Glucose System - A Fluorescence-Based long-term continuous glucose sensor

Ulrike Kamecke, Dipl-Ing (FH) et al.

 

10:08  Wearable Electrochemical Platform for Glucose Monitoring and Diabetes Management

Russell Potts, PhD et al.

 

10:12  Point-of-Care Insulin Monitoring Using Electrochemical Sensing

Clara Stroh et al.

 

10:16  1,5-Anhydroglucitol is an Independent Predictor of Mortality in Patients with COVID-19

Eric Button, MS, MBA et al.

 

10:20  Unsupervised Anomaly Detection Algorithms to Identify Compression Artifacts in Continuous Glucose Monitoring

Elena Idi, MS et al.

 

10:24  Q&A / Panel Discussion

 

Session D

Moderators

Hubert Vesper, PhD

Centers for Disease Control and Prevention, Atlanta, Georgia, USA

 

Lori Laffel, MD, MPH

Joslin Diabetes Center Harvard Medical School, Boston, Massachusetts, USA

 

10:45  Improvements in Hypoglycemia and HbA1c with RT-CGM Adoption: Results from the COACH Study

Stayce Beck, PhD et al.

 

10:49  Long-Term (7-Year) Glycemic Outcomes with Continuous Glucose Monitoring (CGM) Initiation within First Year of Type 1 Diabetes (T1D) Diagnosis

Anagha Champakanath, MBBS et al.

 

10:53  Relationship between Time in Range, Glycemic Variability Metrics and Daily Scan Rate in Children with Type 1 Diabetes

Pietro Bosoni, MSc et al.

 

10:57  A Data-Driven Approach to Predict Carbohydrate Counting Errors in Diabetes Management

Sahaj Shah, BA et al.

 

11:01  Identifying Patients at High Risk for Cystic Fibrosis Related Diabetes through the use of the Freestyle LibrePro CGM

Jeniece Ilkowitz, RN, MA, CDE et al.

 

11:05  Upcycling of Used CGM to a Cool Chain Monitor for Insulin

Thomas Wuttke, Dipl.-Ing. et al.

 

11:09  Q&A / Panel Discussion

 

Session E

Moderators

Francisco Pasquel, MD, MPH

Emory University, Atlanta, Georgia, USA

 

Sultan Meo, MD, PhD, FRCP

King Saud University, Riyadh, Saudi Arabia

 

11:30  Phenolic Preservatives, Present in Commercial Insulins, Trigger Inflammation at Infusion Sites via Mast Cell Activation

Shereen Kesserwan, MS et al.

 

11:34  Rate of Unexplained Hyperglycemia and Infusion Set Occlusion: Medtronic Extended Infusion Set (EIS) Pivotal Trial and 3-day Infusion Set Study Comparison

Sarnath Chattaraj, PhD et al.

 

11:38  Potential Cost Savings from a Reduction in Sensor-detected Severe Hypoglycemia Among Users of the InPen Smart Insulin Pen System

Albert Chien, MA, MPH et al.

 

11:42  User Experiences with an Insulin Pen Platform

April Taylor, MSN, CNS et al.

 

11:46  Preferences for Connected Insulin Pens: A Discrete Choice Experiment Among Type 1 and Type 2 Diabetes Patients

Rachel S. Newson, PhD et al.

 

11:50  Determining losses in Jet-Injection Subcutaneous Insulin delivery

Alex McHugh, BE (Hons) et al.

 

11:54  Q&A / Panel Discussion

 

Session F

Moderators

Wei-An (Andy) Lee, DO

LAC+USC Medical Center, Los Angeles, California, USA

 

Jing Wang, PhD, MPH, RN, FAAN

Florida State University, Tallahassee, Florida, USA

 

12:15  Increased Time-in-Range after Meals When Using the SNAQ App

David Haldimann, MSc et al.

Presented by Aurelian Briner, MA

 

12:19  Representing Type 1 Diabetes Device Data Using CDISC Standards

John Owen, BSc et al.

Presented by Rebecca Baker, MS, MHA, BSN

 

12:23  Development of Self-Management Behavior Scores and Profiles with Digital Health Data

Michelle Dugas, PhD et al.

 

12:27  “Pre-Ramadan” Telemedicine: Effect on Fasting Experience & Glycemic Control during Ramadan in People with Type 1 Diabetes

Sahar Alharthi, MBBS et al.

 

12:31  The Effects of One Drop Digital Program on Glucose Control in Employees with Type 1 and 2 Diabetes

Lindsay Sears, PhD et al.

 

12:35  Virtual Care in the COVID-19 Era: Assessing Telemedicine Experiences among Diabetes Care and Education Specialists

Evelyn Cox, BA et al.

 

12:39  Q&A / Panel Discussion